About Us
Our Vision
To redefine global nutritional standards through the curation and
authentication of the world’s finest swiftlet treasures—bridging
the gap between heritage tradition and precision biotechnology.
Core Business Value Proposition
A New Asset Class
Scientific Intellectual Property
Backed by an extensive portfolio of global patent grants across major economic regions, we have secured the definitive technology for the extraction of highly soluble, next-generation swiftlet peptides.


The DNA Seal of Provenance
Utilizing proprietary DNA-based identification
primers, we provide an immutable “Biological Passport” for every nest, verifying its geographic origin and safeguarding against the multi-billion dollar counterfeit trade.
Bio-Integration
Our peptides are uniquely engineered for seamless formulation with global lifestyle staples, enabling a luxury daily ritual for discerning consumers.

All photos are by Freepik and for illustration purposes only
Key Business Opportunities
The Indonesia Hub (Batam)
Objective:
To establish the world’s definitive Integrated swiftlet/ EBN Library & Processing Hub, modernizing the global supply chain through high-tech infrastructure and Singapore-grade scientific standards.
01
Precision Farming & Estate Management
Action: Deployment of standardized, high-tech agricultural protocols across specialized
estates.
Impact: Optimizing nutrient density and maximizing yield through real-time environmental monitoring.
02
The Global Library & Bio-Sanctuary
Action: Centralizing the gathering of swiftlet harvests from every major producing country
into a single, cataloged repository.
Impact: Creating a global “Standard of Reference” where every nest is identified and profiled for its unique molecular identity.
03
Advanced Clean-Tech Processing
Action: Implementation of proprietary GOPT (Physical
Smart Removal) and GOMT (Microbes-Safe Packaging) technologies.
Impact: Ensuring 100% chemical-free, pharmaceutical-grade purity ready for immediate global export to the most regulated markets.
Our Team

Meet the Founder:
Dr. Lim Kah Meng
The platform’s credibility is anchored by the global scientific authority of Dr. Lim Kah Meng (PhD, Biomedicine), recognized as a leading figure in molecular swiftlet research.
Prolific Innovation:
He has authored numerous patents specifically regarding the extraction processes for bioactive and immunologically active molecules.